pyrazolanthrone has been researched along with Hepatitis B, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, Z; Cheng, Y; Hu, C; Hu, Y; Qian, F; Shi, B; Wang, S; Wu, M; Yuan, Z | 1 |
1 other study(ies) available for pyrazolanthrone and Hepatitis B, Chronic
| Article | Year |
|---|---|
Hepatitis B virus surface antigen selectively inhibits TLR2 ligand-induced IL-12 production in monocytes/macrophages by interfering with JNK activation.
Topics: Anthracenes; Cell Differentiation; Cell Line, Tumor; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; I-kappa B Proteins; Immune Evasion; Interleukin-10; Interleukin-12; Interleukin-12 Subunit p40; Interleukin-1beta; Interleukin-6; Interleukin-8; JNK Mitogen-Activated Protein Kinases; Lipopeptides; Macrophages; Monocytes; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphorylation; RNA, Messenger; Toll-Like Receptor 2; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2013 |